共 70 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20
[3]
Soerjomataram I(2001)Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725-730
[4]
Cunningham D(2014)Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up Eur J Surg Oncol 40 584-591
[5]
Allum WH(1995)Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 345 745-748
[6]
Stenning SP(1996)Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial The Surgical Cooperative Group Lancet 347 995-999
[7]
Macdonald JS(2018)Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial Lancet Gastroenterol Hepatol 3 460-468
[8]
Smalley SR(2016)Long-term survival in patients with postoperative intra-abdominal infectious complications after curative gastrectomy for gastric cancer: A propensity score matching analysis Ann Surg Oncol 23 809-816
[9]
Benedetti J(2014)Prognostic significance of complications after curative surgery for gastric cancer Ann Surg Oncol 21 891-898
[10]
Waddell T(2013)Clinicopathological characteristics and survival difference between gastric stump carcinoma and primary upper third gastric cancer J Gastrointest Surg 17 313-318